Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared Current Oncology MDPI‘s post on LinkedIn, adding:
“Special kudus to our Group on publishing 1st paper at the USMIRC special edition Current Oncology Journal with growth of the future partnership!”
Quoting Current Oncology MDPI‘s post:
“New Article Live | Current Oncology
“BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment”
From the Guest Editor team Al-Ola Abdallah of the Special Issue “U.S. Myeloma Innovations Research Collaborative (USMIRC) Collection“.
Read the full paper here
Interested in contributing?
This Special Issue is open for submissions! Learn more and submit your work
We look forward to your participation and high-quality research!”
Title: BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment
Authors: Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan, Darryl Chang, Barry Pau, Hira Shaikh, Christopher Strouse, Emily Struble, Andrew Vegel, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Joseph P. McGuirk, Al-Ola Abdallah, Shebli Atrash and Reed Friend
More posts featuring Al-Ola Abdallah and Current Oncology MDPI.